Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

70 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

NCT07498335

Conditions
Autoimmune Diseases, Berger Disease, Bergers Disease, +20 more
Locations
  • Hackensack Meridian Health Neptune City, New Jersey, United States
  • Cincinnati Childrens Hospital MC Cincinnati, Ohio, United States
  • University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States
  • University of Tennessee Health Science Center- Le Bonheur Research Center Memphis, Tennessee, United States
View Trial Details
Recruiting

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

NCT07541287

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations
  • Jade Clinical Site Chula Vista, California, United States
  • Jade Clinical Site Arvada, Colorado, United States
  • Jade Clinical Site Denver, Colorado, United States
  • Jade Clinical Site Orlando, Florida, United States
View Trial Details
Recruiting

PS-002 for the Treatment of IgA Nephropathy in Adults

NCT07182227

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations
  • University of Miami Hospital Miami, Florida, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Manchester University NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
View Trial Details
Recruiting

Study of BHV-1400 in IgA Nephropathy

NCT07054684

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • Site-001 Farmington, Connecticut, United States
  • Site-003 Miami Lakes, Florida, United States
  • Site-011 Miami Lakes, Florida, United States
  • Site-013 Orlando, Florida, United States
View all 15 locations
View Trial Details
Recruiting

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

NCT04663204

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, England, United Kingdom
  • Northern Care Alliance NHS Foundation Trust - Salford Royal Salford, England, United Kingdom
  • Royal Infirmary of Edinburgh & Western General Hospital Edinburgh, Scotland, United Kingdom
  • University Hospital of wales Cardiff, Wales, United Kingdom
View Trial Details
Recruiting

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

NCT06676384

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +34 more
Locations
  • Muljibhai Patel Urological Hospital Nadiād, Gujarat, India
  • JSS Medical College Mysuru, Karnataka, India
  • Kasturba Medical College, Manipal Udupi, Karnataka, India
  • KEM Hospital Mumbai, Maharashtra, India
View Trial Details

Related conditions